NCT02881970View on ClinicalTrials.gov

Neonatal Hypoxic Ischemic Encephalopathy : Safety and Feasibility Study of a Curative Treatment With Autologous Cord Blood Stem Cells

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 5, 2020

Primary Completion Date

April 30, 2028

Study Completion Date

September 30, 2028

Conditions
Neonatal Hypoxic-ischaemic Encephalopathy
Interventions
DRUG

autologous cord blood stem cell

Injection of 5.107 / kg autologous mononuclear cells from umbilical cord blood

Trial Locations (1)

Unknown

RECRUITING

Assistance Publique Hopitaux de Marseille, Marseille

All Listed Sponsors
lead

Assistance Publique Hopitaux De Marseille

OTHER